Caredx

This study is testing a new blood test called AlloHeme to see if it can predict when leukemia or a related blood cancer might return after a patient receives a bone marrow transplant. Researchers will track over 300 patients for two years, collecting regular blood and bone marrow…

This study is observing how well a set of blood tests, called LungCare, works for monitoring patients after a lung transplant. It aims to see if a specific test (AlloSure Lung) can accurately detect early signs of organ rejection or infection. The study is following 550 lung tran…

This study is testing whether new blood tests can better monitor liver transplant patients compared to current standard methods. Researchers will follow 1,500 transplant recipients for several years, collecting blood samples regularly to see if these tests can detect problems lik…

This study is a large registry that observes how a specific blood test service is used to monitor heart transplant patients for signs of organ rejection. It involves over 2,700 patients who have received a heart transplant and are using this monitoring service. The goal is to col…